PEOPLE - Shield Diagnostics makes appointment:
This article was originally published in Clinica
UK company Shield Diagnostics has reinforced its relationship with Abbott Diagnostics by appointing Erik Hornnaess to the post of non-executive director. Mr Hornnaess has worked for Abbott Diagnostics for over 10 years and was divisional vice-president for Europe, Africa and the Middle East. Shield and Abbott signed a research agreement in February (see Clinica No 745, p11).
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.